Literature DB >> 29068867

Low Expression of miR-18a as a Characteristic of Pediatric Acute Lymphoblastic Leukemia.

Neda Mosakhani1, Mohamed El Missiry, Emmi Vakkila, Sakari Knuutila, Jukka Vakkila.   

Abstract

BACKGROUND: Acute lymphoblastic leukemia (ALL) occurs in both adults and children but the response to chemotherapy and survival is significantly worse in the adults. We aimed to study whether the expression of immune system-associated miRNAs would differ between adult and pediatric patients with ALL at the time of diagnosis.
MATERIALS AND METHODS: Inflammation-associated miRNA analysis was performed in 19 adults and 79 pediatric patients with ALL and involved miR-10, miR-15, miR-16, miR-17-92 cluster, miR-33, miR-146a, miR-150, miR-155, miR-181a, miR-222, miR-223, and miR-339. MiRNAs were first analyzed by miRNA microarray and thereafter validated by qRT-PCR. Sufficient RNA for qRT-PCR was available for 42 pediatric and 19 adult patients.
RESULTS: Of the studied miRNAs, only miR-18a differed significantly in microarray analysis between adult and pediatric ALL, being lower in children (FC, -3.74; P, 0.0037). Results were confirmed by qRT-PCR (down-regulated in pediatric patients, P 0.003161). The other members of the miR-17-92 cluster did not differ significantly.
CONCLUSIONS: Pediatric and adult patients with ALL have remarkably similar patterns of immune-cell-associated miRNAs in their bone marrow at diagnosis. However, the low expression of miR-18a in pediatric ALL is interesting and demands further study.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29068867     DOI: 10.1097/MPH.0000000000000921

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  Leonurine-Repressed miR-18a-5p/SOCS5/JAK2/STAT3 Axis Activity Disrupts CML malignancy.

Authors:  Hui-Min Liu; Chun-Ling Guo; Yao-Fang Zhang; Jian-Fang Chen; Zhi-Peng Liang; Lin-Hua Yang; Yan-Ping Ma
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

2.  Identification of potential pathways and microRNA-mRNA networks associated with benzene metabolite hydroquinone-induced hematotoxicity in human leukemia K562 cells.

Authors:  Chun-Hong Yu; Shui-Qing Yang; Lei Li; Yu Xin; Fang Zhang; Xiao-Fan Liu; Zong-Chun Yi
Journal:  BMC Pharmacol Toxicol       Date:  2022-04-02       Impact factor: 2.483

Review 3.  MiRNA Dysregulation in Childhood Hematological Cancer.

Authors:  Jaqueline Carvalho de Oliveira; Gabriela Molinari Roberto; Mirella Baroni; Karina Bezerra Salomão; Julia Alejandra Pezuk; María Sol Brassesco
Journal:  Int J Mol Sci       Date:  2018-09-10       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.